Purpose Many studies have determined cancer patients' preferences for adjuvant therapy,
for example, by asking patients the extent of benefit they would need in order to accept the …

PURPOSE: In the era of evidence-based medicine and shared decision making, the formal
assessment of patient preference for treatments or treatment outcomes has attracted much …

BACKGROUND Published studies have suggested that most patients with early stage breast
cancer are willing, for modest survival benefits, to receive 6 months of adjuvant …

Objective: Using an interview-guided survey, our descriptive study aimed to document the
extent to which cancer patients perceive they are involved in making treatment decisions …

Purpose The aim of this study was to analyze differences in physician and patient
satisfaction in shared decision-making (SDM); patients' emotional distress, and coping in …

PURPOSE: To document the adequacy of patient information in oncology consultations
concerning adjuvant therapy and explore predictors of physician communication patterns …

This review provides cancer clinicians and researchers with an overview of methods for
assessing preferences, with examples and recommendations for their application in …

This study examined patients' preferences for involvement in treatment decision-making.
This was a multisite survey study of 1014 patients diagnosed with a variety of cancers …

Treatment decisions in life‐threatening diseases, like colorectal cancer (CRC), are crucial,
since they have a great impact on patient's survival and health‐related quality of life …

Cancer patients vary in their preferred level of involvement in medical decision making, and
responding to patients' desired level of involvement is a key element of good medical care …